Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1954199 | 0.89 | ALDH1A1 (0.47) | ALDH1A1MAPK1LMNAMAPTKMT2A | |
| SCHEMBL1834514 | 0.86 | ALDH1A1 (0.48) | ALDH1A1MAPK1LMNAMAPTATM | |
| SCHEMBL1952405 | 0.85 | ALDH1A1 (0.47) | ALDH1A1MAPK1LMNAMAPTMEN1 | |
| SCHEMBL11765486 | 0.85 | ALDH1A1 (0.56) | ALDH1A1MAPK1LMNAMEN1KMT2A | |
| SCHEMBL1839851 | 0.85 | ALDH1A1 (0.44) | ALDH1A1MAPK1LMNAMAPTMEN1 | |
| SCHEMBL1021748 | 0.84 | ALDH1A1 (0.50) | ALDH1A1MAPK1LMNAMAPTMEN1 | |
| SCHEMBL12288926 | 0.84 | MAPK1 (0.65) | ALDH1A1MAPK1MAPTMEN1KMT2A | |
| SCHEMBL989117 | 0.84 | ALDH1A1 (0.60) | ALDH1A1MAPK1LMNAMAPTMEN1 | |
| SCHEMBL1839274 | 0.83 | ALDH1A1 (0.46) | ALDH1A1MAPK1LMNAATMNPC1 | |
| SCHEMBL13859992 | 0.82 | ALDH1A1 (0.55) | ALDH1A1MAPK1LMNAMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11192853-B2 | Separation method and method for producing isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2021-12-07 | — | — | US | disclosed |
| EP-2641896-B1 | SEPARATION METHOD | ASAHI CHEMICAL IND (JP) | 2020-10-14 | — | — | EP | disclosed |
| EP-2679575-B1 | PROCESS FOR PRODUCING CARBONYL COMPOUNDS | ASAHI CHEMICAL IND (JP) | 2019-04-10 | — | — | EP | disclosed |
| EP-2626345-B1 | SEPARATION METHOD AND METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2019-01-16 | — | — | EP | disclosed |
| US-9950273-B2 | Method of separation | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-04-24 | — | — | US | disclosed |
| US-20180105489-A1 | Separation Method and Method for Producing Isocyanate | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-04-19 | — | — | US | disclosed |
| US-9884810-B2 | Separation method and method for producing isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-02-06 | — | — | US | disclosed |
| US-9714215-B2 | Method for producing isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2017-07-25 | — | — | US | disclosed |
| US-20160052874-A1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-02-25 | — | — | US | disclosed |
| US-9145358-B2 | N-substituted carbamic acid ester production method, isocyanate production method using such N-substituted carbamic acid ester, and composition for transfer and storage of N-substituted carbamic acid ester comprising N-substituted carbamic acid ester and aromatic hydroxy compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-09-29 | — | — | US | disclosed |
| US-20140332367-A1 | Method of Separation | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-11-13 | — | — | US | disclosed |
| US-20140194644-A1 | N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, and Composition for Transfer and Storage of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-07-10 | — | — | US | disclosed |
| EP-2641896-A1 | SEPARATION METHOD | Asahi Kasei Chemicals Corporation (JP) | 2013-09-25 | — | — | EP | disclosed |
| EP-2626345-A1 | SEPARATION METHOD AND METHOD FOR PRODUCING ISOCYANATE | Asahi Kasei Chemicals Corporation (JP) | 2013-08-14 | — | — | EP | disclosed |
| US-20130184488-A1 | Separation Method and Method for Producing Isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2013-07-18 | — | — | US | disclosed |
| US-20130178645-A1 | Method for Producing Carbonyl Compund | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2013-07-11 | — | — | US | disclosed |
| US-20110160476-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-06-30 | — | — | US | disclosed |
| US-20110133121-A1 | N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-06-09 | — | — | US | disclosed |
| EP-2322504-A1 | PROCESS FOR THE PREPARATION OF N-SUBSTITUTED CARBAMIC ACID ESTER AND PROCESS FOR THE PREPARATION OF ISOCYANATE USING THE N-SUBSTITUTED CARBAMIC ACID ESTER | Asahi Kasei Chemicals Corporation (JP) | 2011-05-18 | — | — | EP | disclosed |
| US-4005056-A | Process for the preparation of polyhydantoins and polyparanic acids | BAYER AKTIENGESELLSCHAFT (DT) | 1977-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110133121-A1 | N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound | CPS1, ALKBH3, RCC1 | ALDH1A1 1568/4885MAPK1 4376/4885LMNA 1776/4885 |
| US-20130178645-A1 | Method for Producing Carbonyl Compund | CA6, CPS1, C9 | ALDH1A1 483/4885MAPK1 3831/4885LMNA 2133/4885 |
| US-20140332367-A1 | Method of Separation | CCKBR, MAOB, CA9 | ALDH1A1 259/4885MAPK1 2939/4885LMNA 1877/4885 |
| US-20110160476-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ALKBH3, CPS1, APEH | ALDH1A1 574/4885MAPK1 4255/4885LMNA 2324/4885 |
| US-11192853-B2 | Separation method and method for producing isocyanate | IDH3A, IDH3B, CA9 | ALDH1A1 278/4885MAPK1 1889/4885LMNA 1338/4885 |
| US-20130184488-A1 | Separation Method and Method for Producing Isocyanate | IDH3A, IDH3B, CA9 | ALDH1A1 278/4885MAPK1 1889/4885LMNA 1338/4885 |
| US-20180105489-A1 | Separation Method and Method for Producing Isocyanate | IDH3A, IDH3B, CA9 | ALDH1A1 278/4885MAPK1 1889/4885LMNA 1338/4885 |
| US-20160052874-A1 | METHOD FOR PRODUCING ISOCYANATE | CPS1, ALKBH3, IDH3A | ALDH1A1 1861/4885MAPK1 4134/4885LMNA 1301/4885 |
| US-20140194644-A1 | N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, and Composition for Transfer and Storage of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound | CPS1, ALKBH3, RCC1 | ALDH1A1 1568/4885MAPK1 4376/4885LMNA 1776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.